Biomanufacturing and Process Development (BPD)
BPD’s mission is to provide a forum for process development and manufacturing scientists and engineers to discuss bioprocessing issues. The group meets approximately eight to ten times a year with speakers from academia, industry, technology vendor experts, and regulatory experts. This is one of the 20-plus Exchange Groups that are supported statewide by NCBiotech.
Faculty, students, postdocs and industry members with interest in BPD are welcome.
Similar meeting format as previous years will be maintained in the 2018-2019 season. Each event will host multiple speakers centered around the event theme, allow a time for networking among attendees, and optionally include a vendor show or poster presentations.
Most events run from 12:30 to 5 p.m. at NCBiotech, unless otherwise noted. Registration is required for all seminars. Registration is $25 for industry/faculty, $5 for graduate/postdoctoral students and FREE for unemployed job seekers, unless otherwise noted.
Request information about monthly meeting and vendor sponsorship packages.
For other information, contact Nikki Pavlides.
September 2018 - Networking Facility Tour*
October 24th, 2018 - Future of Manufacturing Symposium and Vendor Show
"The Use of Bio-capacitance to Improve Consistency in Cell Culture Processes"
Taylor Forte, engineer I, Cell Culture Development, Biogen
Keith Selvitelli, scientist I, Process Biochemistry, Biogen
"Inspiring Advances in Bioprocessing"
Mario Sinani, field application specialist, Repligen
"Implementation of Protein A Multi-Column Chromatography at Process Scale"
Denis Kole, senior principal scientist, Biopharm SLS, Continuous Bioprocessing, Pall
"Innovations Drive Changes in Antibody Purification Systems"
John Jenco, senior bioprocess applications scientist, GE Healthcare
"Application of Single Pass TFF to Enable Intensified and Continuous Biological Manufacturing"
Josh Arias, MilliporeSigma
November 29, 2018 - Novel Modalities Symposium
“Preparing for the Future Growth of Oligonucleotide Therapies”
Sheron Branham, MBA, associate director, ASO Process Engineering and Manufacturing, Biogen
“Scaling Up of Stem Cell Production for Research and the Clinic”
Barbara Ressler, Ph.D., director, Cell Therapy Product Development, Marcus Center for Cellular Cures, Duke University
"A Rapid Affinity Purification Technology and Supply Platform to Address the Manufacturing Complexities of Novel Modalities"
Dan Freymeyer, head of business development, Avitide Inc.
"Challenges in Allogenic CAR T Cell Manufacture"
Kim Nguyen, director, Process Development, Precision BioSciences
January 17, 2019 - Education and Training Spotlight
Introductory presentation: “The Biopharmaceutical Training and Education Landscape in North Carolina”
Panel discussion: "Faces of Success"
Former students from local educational programs will discuss how these programs helped to prepare them for a career in the biopharmaceutical industry.
Panel discussion: "Path to Success"
Hiring managers will share their views on skills needed for a successful career in the biopharmaceutical industry.
There are several opportunities to network with training/education organizations at booths.
BTEC (at NC State University), BRITE (at NC Central University), BioNetwork, East Carolina University, BioWork Program, Campbell University, ISPE, NCBiotech, Vance-Granville Community College, Wake Technical Community College
March 7, 2019 - Product Life Cycle Strategies Symposium
"Phase in and Phase out of new portfolio solutions- Knowing when to make the jump"
Brenda Beauchamp, bioMerieux
"Getting good at change - leveraging your domestic products internationally and doing it well"
Brandon Buchanon, Novo Nordisk
"Biologic Products LCM: New indications, New formulations, New routes of administration, New markets"
Dee Parson Grange, Grifols
"Fulfilling the promise of regenerative medicine through lifecycle improvements"
Alex Tracy, Enzyvant
April 11, 2019 - Cell and Gene Therapy Symposium and Vendor Show
Cell Therapy (10:00 - 11:45 am)
“Manufacturing Solutions Driving Rapid Clinical Translation of hMSCs and hMSC-Based Therapeutics”
Priya Baraniak, Ph.D., Senior Director, Business Development ROOSTER BIO
“Steps to Reduce Bioburden from Human Livers during Manufacturing of Hepatocytes”
Jeremy Smith, B.S., Head of Quality Control, PROMETHERA
“Off the Shelf Chimeric Antigen Receptor (CAR) T Cell Therapy for the Treatment of Cancer”
Mark Johnson, Ph.D., Team Leader, Cell Therapy Discovery, PRECISION BIOSCIENCES
Gene Therapy (1:25-3:20 pm)
“Regulatory Obstacles for Starting Cell and Gene Therapy Trials”
Stephanie Pierce, Ph.D., RAC, Regulatory Affairs Scientist, OFFICE OF REGULATORY AFFAIRS AND QUALITY, DUKE UNIVERSITY SCHOOL OF MEDICINE
“Adeno-Associated Virus Biology and Bioprocessing”
William (Billy) Kish, Ph.D., Senior Scientist, Gene Therapy Process Development, PFIZER (BAMBOO)
“Innovation in AAV Manufacturing - Vertical Integration and Continuous Improvement”
Jacob Smith, B.S., Director of Process Development, ASKBIO
We'd like to thank our participating vendors:
ACGT, Inc. Applikon Biotechnology, Beckman Coutler Life Sciences, Bio-Rad, Charles River, Charter Medical, Kymanox, Pall Biotech, PBS Biotech, STI, Synthego, Waston Marlow, and Waters
May 9, 2019 - Comparability/Characterization Symposium
**Monthly Meeting and Vendor Sponsorship Packages available, for more information, contact Hannah_cole@ncbiotech.org**
Steering Committee Members 2018-2019
Hannah Cole, North Carolina Biotechnology Center
Stewart Kohnberg, Tokyo Chemical Industry Co., Ltd.
Nikki Pavlides, Ph.D., Kymanox
Michael David, Eppendorf
Ronna Dornsife, NCCU BRITE
Gary Gilleskie, NC State University (BTEC)
Zach Koontz, Waters Corp.
Thomas Parker, MilliporeSigma
Caroline Smith-Moore, NC State University (BTEC)
Stacey Traviglia, Ph.D., Biogen
Matthew Tyson, Duke Human Vaccine Institute
Kevin Williams, NCCU (BRITE)
Jennifer Zhang, Biogen
To be added to our mailing list, please fill out the Interest Form.